video library

Facility Spotlight: Winnipeg, Manitoba, Canada

For more than 30 years, our Winnipeg, Manitoba (Canada) site has offered a broad range of expertise for drug substance and drug product manufacturing. The 150,000-sq.ft. facility manufactures polyclonal hyperimmune products, plasma therapeutics, lipoproteins, and mRNA products, and houses a SA25 aseptic filling workcell — a gloveless, robotic isolator ideal for high-value biologic products.

HubSpot Video

Learn more about how our Winnipeg site is equipped to support your next clinical or commercial drug candidate.

A look inside our Center of Excellence for Development Services

From analytical development to drug substance and drug product process development and scale-up, we can help advance your...


Learn more about our site in Switzerland

Located in Thörishaus, Switzerland, just outside of Bern, our European-based site has expertise in mammalian, microbial, and...


Arrival of the Groninger INTEGRA

With the expansion of our viral drug product manufacturing facility in Rockville, Maryland well underway, we have begun...